Biotech

eye doctor opthalmology phoropter glasses eye disease vision
Biotech

Outlook's eye disease drug fails to match Lucentis, sinking stock

The biotech brushed off the failure, noting positive details and vowing to seek FDA approval, but investors were less sanguine about the setback.
Nick Paul Taylor Nov 27, 2024 8:40am
Money in the hands of businessmen with contract signing

PTC sells priority review voucher from Kebilidi nod for $150M

Nov 27, 2024 8:35am
Hybrid FSPFSO Solutions Keep Biotech Trials on Time and on Budget

Hybrid FSP/FSO Solutions Keep Biotech Trials on Time and on Budget

Nov 1, 2024 8:00am
Missed target failed trial trial failure

PTC axes utreloxastat program after phase 2 ALS failure

Nov 27, 2024 4:45am
video
Carl Sailer on AI market trends and strategic planning in biotech

Carl Sailer on AI, market trends, and strategic planning in biotech

Oct 28, 2024 8:00pm
A series of dice with a bag on them illustrating cost cuts

Idorsia teases Tryvio licensing deal while planning 270 layoffs

Nov 27, 2024 4:15am